Compound 1963
Identifiers
- Canonical SMILES:
CN(Cc1cc(Cl)cc(c1O)-c1cc(-c2cc(ccc2Cl)C(F)(F)F)c(C#N)c(=O)[nH]1)C(=O)C1CCN(CC1)C(=O)OC(C)(C)C
- IUPAC name:
tert-butyl 4-{[(5-chloro-3-{4-[2-chloro-5-(trifluoromethyl)phenyl]-5-cyano-6-oxo-1,6-dihydropyridin-2-yl}-2-hydroxyphenyl)methyl](methyl)carbamoyl}piperidine-1-carboxylate
- InChi:
InChI=1S/C32H31Cl2F3N4O5/c1-31(2,3)46-30(45)41-9-7-17(8-10-41)29(44)40(4)16-18-11-20(33)13-23(27(18)42)26-14-21(24(15-38)28(43)39-26)22-12-19(32(35,36)37)5-6-25(22)34/h5-6,11-14,17,42H,7-10,16H2,1-4H3,(H,39,43)
- InChiKey:
ARNVETFRRGWWOB-UHFFFAOYSA-N
External links
![]() 44431592 |
![]() CHEMBL394046 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Survivin dimer | 6.59 | cancer | Stabilization |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 678.16 g/mol | |||
HBA | 9 | |||
HBD | 2 | |||
HBA + HBD | 11 | |||
AlogP | 4.98 | |||
TPSA | 120.17 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2007.03.042 | 23f | BIRC5 O15392 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 6.59 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5377 | 6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | DB08705 | |
0.4375 | Losmapimod | DB12270 | |
0.4357 | CPI-1205 | DB14581 | |
0.4352 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE | DB07025 | |
0.4332 | Garenoxacin | DB06160 | |
0.4245 | Batefenterol | DB12526 | |
0.4214 | Topotecan | DB01030 | |
0.4213 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | DB07006 | |
0.4200 | Tazemetostat | DB12887 | |
0.4185 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4170 | Talnetant | DB06429 | |
0.4169 | Irinotecan | DB00762 | |
0.4152 | JPC-3210 | DB15609 | |
0.4130 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4105 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID | DB07265 |